Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Next-generation sequencing in oncology: challenges in economic evaluations.

Expert review of pharmacoeconomics & outcomes research - 1 Dec 2024

Ehman Morgan, Punian Jesman, Weymann Deirdre, Regier Dean A

Abstract excerpt

INTRODUCTION: Next-generation sequencing (NGS) identifies genetic variants to inform personalized treatment plans. Insufficient evidence of cost-effectiveness impedes the integration of NGS into routine cancer care. The complexity of personalized treatment challenges conventional economic evaluation. Clearly delineating challenges informs future cost-effectiveness analyses to better value and contextualize...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cost-Benefit Analysis
Share to Decision Making
Share to Delivery of Health Care

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Variation

Share to High-Throughput Nucleotide Sequencing

Share to Medical Oncology

Share to Neoplasms

Share to Precision Medicine

Source

Identifiers

PMID: 39096135
DOI: 10.1080/14737167.2024.2388814

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Next-generation sequencing in oncology: challenges in economic evaluations.PMID 39096135Read ↗

Clinical and Economic Value of Genetic Sequencing for Personalized Therapy in Non-small-cell Lung Cancer.Semantic proximity Read ↗

Scenario drafting for early technology assessment of next generation sequencing in clinical oncology.Semantic proximity Read ↗

Application of next-generation sequencing to improve cancer management: A review of the clinical effectiveness and cost-effectiveness.Semantic proximity Read ↗

Value-based genomicsSemantic proximity Read ↗

Supporting Biomarker-Driven Therapies in Oncology: A Genomic Testing Cost Calculator.Semantic proximity Read ↗

Genomic testing in oncology to improve clinical outcomes while optimizing utilization: the evolution of diagnostic testing.Semantic proximity Read ↗

Decision impact studies, evidence of clinical utility for genomic assays in cancer: A scoping reviewSemantic proximity Read ↗

Costs and Benefits of Whole-Exome, Whole-Transcriptome Sequencing in Patients With Advanced Non–Small Cell Lung CancerSemantic proximity Read ↗

Micro-costing Diagnostics in Oncology: From Single-Gene Testing to Whole Genome SequencingSemantic proximity Read ↗

Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French studySemantic proximity Read ↗

Next‐generation sequencing in precision oncology: Patient understanding and expectationsSemantic proximity Read ↗

Real-world cost-effectiveness of panel-based genomic testing to inform therapeutic decisions for metastatic colorectal cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.